Response to "Dose Rationale for Favipiravir Use in Patients Infected With SARS‐CoV‐2"-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Response to "Dose Rationale for Favipiravir Use in Patients Infected With SARS‐CoV‐2"

Published:2020-05-21 Issue:2 Volume:108 Page:190-190
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Du Yin‐Xiao¹²³,Chen Xiao‐Ping¹²³

Affiliation:

1. Department of Clinical Pharmacology Xiangya Hospital Central South University Changsha Hunan China

2. Institute of Clinical Pharmacology Hunan Key Laboratory of Pharmacogenetics Central South University Changsha Hunan China

3. National Clinical Research Center for Geriatric Disorders Xiangya Hospital Central South University Changsha Hunan China

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1878

Reference5 articles.

1. Dose rationale for favipiravir use in patients infected with SARS‐CoV‐2;Eloy P.;Clin. Pharmacol. Ther.,2020

2. Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019‐nCoV Infection

3. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

4. Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS‐CoV‐2 replication in vitro;Choy K.‐T.;Antiviral. Res.,2020

5. Favipiravir versus arbidol for COVID‐19: a randomized clinical trial;Chen C.;bioRxiv

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel LC-MS/MS method for the determination of favipiravir ribofuranosyl-5’-triphosphate (T-705-RTP) in human peripheral mononuclear cells;Journal of Pharmaceutical and Biomedical Analysis;2024-08

2. Reviewing the insights of SARS-CoV-2: Its epidemiology, pathophysiology, and potential preventive measures in traditional medicinal system;Clinical Traditional Medicine and Pharmacology;2024-06

3. Extraction of Covid-19 drug (Favipiravir) from plasma samples by yolk-shell mesoporous silica before HPLC-MS/MS determination;Journal of Pharmaceutical and Biomedical Analysis;2024-02

4. First electropolymerized carbidopa-based molecularly imprinted film: Disposable electrochemical sensor for monitoring of anti-COVID-19 drug favipiravir in human plasma;Microchemical Journal;2024-01

5. Development and validation of method for analysis of favipiravir and remdesivir in volumetric absorptive microsampling with ultra high-performance liquid chromatography–tandem mass spectrophotometry;Frontiers in Medicine;2023-05-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3